Skip to main content
Tech.euFundingExplorerBeta

MinervaX

Minervax ApS develops vaccines against Group B streptococcus (GBS) infections

MinervaX has raised €178M across 5 funding rounds from 16 investors, most recently a round in Oct 2023. Based in Hellerup, Denmark; founded 2010; active in Healthtech. Data as of 28 Oct 2026.

Hellerup, DenmarkFounded 2010minervax.com ↗
Total raised
€178M
€177,800,000
Funding rounds
5
Investors
16
distinct backers
Active since
2019-01
latest 2023-10

Funding by year

EUR raised per year
MinervaX — funding by year — interactive chart.
Data table
MinervaX — funding by year
2018€4.4M
2020€47M
2022€72M
2023€54M

Signals

High confidence
Raise-next likelihood6
base rate 30% for Other
  • ▼ Past typical raise window
  • ▼ Low backer re-investment
Exit likelihood12
base rate 11% (2+ rounds)
  • ▲ €100M+ raised
  • ▲ 5 rounds raised
  • ▼ Old (16y) — past typical exit age
  • ▼ No recent equity round (debt-only or quiet)

Timing: overdue vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.